Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06932653

Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial

SurgPASS is a pilot randomised cluster trial utilising a pre-operative checklist with the aim of reducing deaths after surgery. If SurgPASS is successful, the intervention will be implemented in a separate full-scale cluster randomised trial.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Abomey-Calavi, Abomey-Calavi, Cotonou, Benin

Loading trial locations.

About this study

Title: Reducing deaths after surgery in low- and middle-income countries: A pilot cluster randomised trial

Aim: This pilot randomised cluster trial aims to evaluate the feasibility of a large-scale cluster randomised trial to assess the effectiveness and implementation of a pre-operative checklist to reduce deaths after surgery. If this pilot study is successful, we aim to assess the intervention in a separate full-scale cluster randomised trial.

  • Objective 1: To determine feasibility and fidelity of delivering the intervention.
  • Objective 2: To determine the rate recruitment to inform how long it will take to recruit to a future cluster randomised trial.
  • Objective 3: To obtain information on postoperative outcomes to help inform the outcomes used and sample size of the future cluster randomised trial.

Design: Pilot cluster randomised trial.

Inclusion: Adult (>18 years old) non-pregnant patients undergoing emergency abdominal surgery with an incision of ≥5cm.

Exclusion: Patients undergoing minimally invasive surgery, or surgery for appendicitis.

Intervention: SurgPASS is an intervention of a preoperative checklist for early recognition and treatment of acutely unwell surgical patients implemented through simulation training and clinical champions.

Comparator: Usual care as per local practice at that site.

Follow-up period: 30-days from surgery.

Number of participants: 300 participants: 25 participants in each of 12 clusters (hospitals), from 6 countries.

Outcomes: Since this is a pilot study, there are no pre-specified primary outcomes. However, there are four key outcomes of interest to assess ahead of the main phase randomised clinical trial.

  • Outcome 1: Measure simulation training and checklist completion rate for participants undergoing surgery to refine future implementation (intervention clusters only)
  • Outcome 2: Measure duration of time to recruit 25 participants per cluster (to determine duration of potential full trial)
  • Outcome 3: Measure 30-day overall complication rates to inform overall sample size of potential full trial

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing emergency major abdominal surgery (i.e., midline or non-midline) with an incision greater than or equal to 5cm
  • Patient must not be pregnant
  • Adults only (greater than or equal to 18 years old)

Exclusion criteria

  • Minimally invasive surgery
  • Surgery for appendicitis

Treatment and study plan

SurgPASS - intervention

Other

SurgPASS consists of a preoperative surgical passport used for any patients requiring emergency laparotomy, a simulation training course and local clinical champions.

Primary outcomes

  1. Training and checklist completion

    Time frame: Within 30 days postoperatively

    Measure simulation training and checklist completion rate for participants undergoing surgery to refine future implementation (intervention clusters only)

Other outcomes

  1. Duration of time to recruit sample size per cluster

    Time frame: Within 6 months post cluster activation

    Measure duration of time to recruit 25 participants per cluster (to determine duration of potential full trial)

  2. Complication rates

    Time frame: Within 30 days postoperatively

    Measure 30-day overall complication rates to inform overall sample size of potential full trial

Study contacts

Contact information is provided by the study sponsor or research team.

Divya Kapoor

CONTACT

[email protected]

+44 (0)121 415 9103

Rachel Lillywhite

CONTACT

[email protected]

+44 (0)121 415 9103

Sponsors and collaborators

Lead sponsor

University of Birmingham

Other

Collaborators

  • Christian Medical College and Hospital, Ludhiana, India
  • Lagos State University
  • Ministry of Health, Ghana
  • University Teaching Hospital of Kigali
  • Université d'Abomey-Calavi

Registry information

Official study title

SurgPASS: Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial

Acronym: SurgPASS

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Apr 17, 2025
Registry last updated
Apr 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.